Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JPMHC 2020
JPMHC 2020
Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings
Fierce Pharma
Wed, 01/22/20 - 11:16 am
Merck
Ken Frazier
Pharma CEOs
JPMHC 2020
Gardasil
vaccines
drug manufacturing
After big year, RNAi drugmakers compete to prove what comes next
BioPharma Dive
Sat, 01/18/20 - 07:37 pm
RNAi
JPMHC 2020
Alynylam
Arrowhead Pharmaceuticals
Dicerna Pharmaceuticals
The truth about JPM: Less is more
Stat
Fri, 01/17/20 - 11:56 pm
JPMHC 2020
JPM: Biotech, VC execs on where the industry should look beyond cancer
Fierce Biotech
Fri, 01/17/20 - 12:34 pm
oncology
cancer
Alzheimer's disease
diabetes
venture capital
JPMHC 2020
Celltrion plans to launch a biosimilar each year for next decade
Pharmaforum
Fri, 01/17/20 - 12:16 pm
Celltrion
South Korea
biosimilars
JPMHC 2020
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
Reuters
Fri, 01/17/20 - 12:12 pm
Lilly
M&A
JPMHC 2020
BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy
Motley Fool
Thu, 01/16/20 - 11:27 pm
Biomarin
JPMHC 2020
drug pricing
valrox
hemophilia
Think JPM seemed slow this year? You're not alone—and here's why
Fierce Pharma
Thu, 01/16/20 - 11:17 pm
JPMHC 2020
M&A
JPM sound bites, vol. 1: Couch shopping, cool drones and 'smelling the turkey'
Fierce Pharma
Thu, 01/16/20 - 11:11 pm
JPMHC 2020
JPM: Glaxo sees enormous Shingrix potential, but a supply gap still stands in the way
Fierce Pharma
Thu, 01/16/20 - 12:22 pm
GSK
vaccines
Shingrix
shingles
drug shortages
JPMHC 2020
J.P. Morgan Trends: Digital Health Confusion, Tech, Drug Prices and Diversity
BioSpace
Thu, 01/16/20 - 10:22 am
JPMHC 2020
M&A
diversity
digital health
technology
drug pricing
After IPO, BioNTech nabs cell therapy startup Neon Therapeutics
Fierce Biotech
Thu, 01/16/20 - 10:19 am
JPMHC 2020
BioNTech
Neon Therapeutics
M&A
GSK, Pfizer contradict on the future of consumer health JV — report
Endpoints
Thu, 01/16/20 - 10:03 am
GSK
Pfizer
consumer health
JPMHC 2020
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Wed, 01/15/20 - 10:49 am
Novartis
Pharma CEOs
Vas Narasimhan
drug launches
JPMHC 2020
JPM: Mayo Clinic, nference launch ambitious data platform initiative
Fierce Biotech
Wed, 01/15/20 - 10:20 am
JPMHC 2020
Mayo Clinica
nference
data analytics
healthcare data
analytics
JPM: Already prepping for Alzheimer's launch, Biogen scouts 'top talent' and talks pricing
Fierce Pharma
Tue, 01/14/20 - 10:49 am
Biogen
Alzheimer's disease
drug pricing
aducanumab
JPMHC 2020
JPM: Alnylam CEO looks to action-packed 2020 on the heels of Givlaari approval
Fierce Pharma
Tue, 01/14/20 - 10:44 am
Alnylam
RNAi
Givlaari
John Maraganore
JPMHC 2020
JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise
Fierce Biotech
Tue, 01/14/20 - 10:19 am
JPMHC 2020
M&A
Gilead Sciences
Bristol-Myers Squibb
GSK’s CEO Walmsley aiming for six new approvals in 2020
Pharmaforum
Tue, 01/14/20 - 10:07 am
GSK
Pharma CEOs
Emma Walmsley
JPMHC 2020
Zejula
Trelegy
daprodustat
belantamab mafodotin
JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another
Fierce Pharma
Mon, 01/13/20 - 11:55 pm
JPMHC 2020
Teva Pharmaceuticals
Novartis
Gilead Sciences
M&A
Pharma CEOs
Pages
1
2
next ›
last »